{"disease":{"id":"advanced-liver-fibrosis","name":"advanced liver fibrosis"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03884062","title":"Clinical Impacts of Achieving SVR in Patients With Advanced Hepatic Fibrosis Related to Chronic HCV Treated With Direct Acting Antivirals","phase":"","overall_status":"COMPLETED","enrollment_count":3000,"lead_sponsor_name":"Egyptian Liver Hospital","has_results":false},{"nct_id":"NCT05602870","title":"Advanced Chronic Liver Disease Screening by Transient Elstography in Patients Hospitalised in a Psychiatric Unit","phase":"NA","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false},{"nct_id":"NCT05939947","title":"A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Alentis Therapeutics AG","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}